2,197
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy

ORCID Icon, , , , , , , , , , , & show all
Pages 1502-1505 | Received 09 Nov 2020, Accepted 22 Dec 2020, Published online: 08 Jan 2021
 

Acknowledgments

AG, TC, PI and KL wrote the manuscript. PB, FM, SL, TC, PI, AM, KL and AG contributed to the acquisition and analysis of the data. TU, JP, AM, EB and MM contributed and revised the manuscript. All authors approved the submitted and final version.

Disclosure statement

EB reports speaker fees from Alexion Pharmaceuticals.

The remaining authors have no actual or potential conflict of interest to declare in relation to this study.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.